Key result
This review summarizes the goals, pharmacokinetics, pharmacodynamics, and clinical data of available and developing anticoagulant therapies for percutaneous coronary intervention.
Population
Patients undergoing percutaneous coronary intervention (PCI) for ischemic heart disease
Design
Review
Authors
Loading...
Provides clinicians a consolidated PCI anticoagulation reference; leaves open optimal use of developing agents.
This review summarizes the goals, pharmacology, and clinical data of anticoagulant therapy during percutaneous coronary intervention.
Rao et al. (2010) conducted a review in Ischemic heart disease undergoing percutaneous coronary intervention. Anticoagulant therapy was evaluated. This review summarizes the goals, pharmacokinetics, pharmacodynamics, and clinical data of available and developing anticoagulant therapies for percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: